Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc. - Stock Titan
2024-08-06 • Google News
Aeterna Zentaris Inc (AEZS)
US$ 5.85-2.06%
Price Chart
Key Statistics
Market Cap
$ 17.51M
P/E Ratio
0.00
Revenue (TTM)
$ 2.37M
Volume
1.51K
52W High
$ 11.10
52W Low
$ 3.96
Dividend Yield
0.00%
Beta
2.26
Technicals
50-Day MA
5.6076
200-Day MA
5.4237
52 Week High
11.1
52 Week Low
3.96
About AEZS
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests in Canada, Switzerland, Ireland, Denmark, Germany, the United .
Employees
N/A
Headquarters
Toronto, Canada
CEO
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg